LGND
Ligand Pharmaceuticals Incorporated
Stock
$302.96+0.22 (+0.07%)Close Oct 2, 2026
- Research and development, 2025
- $81M
- YoY, 2025
- +278.9%
- 5-year CAGR
- +14.9%
- 10-year CAGR
- +22.1%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $81M | +278.9% |
| 2024 | $21M | −12.7% |
| 2023 | $25M | −32.0% |
| 2022 | $36M | +12.4% |
| 2021 | $32M | −20.7% |
| 2020 | $41M | −27.6% |
| 2019 | $56M | +100.7% |
| 2018 | $28M | +3.6% |
| 2017 | $27M | +26.7% |
| 2016 | $21M | +92.8% |
| 2015 | $11M | +12.9% |
| 2014 | $9.7M | +5.1% |
| 2013 | $9.3M | −14.1% |
| 2012 | $11M | +4.8% |
| 2011 | $10M | −53.4% |
| 2010 | $22M | −44.7% |
| 2009 | $40M | — |